Recurrence of conjunctival goblet cells after discontinuation of dupilumab in a patient with dupilumab-related conjunctivitis

Voorberg, A N; den Dunnen, W F A; Wijdh, R H J; de Bruin-Weller, M S; Schuttelaar, M L A

doi:https://doi.org/10.1111/jdv.15914

Recurrence of conjunctival goblet cells after discontinuation of dupilumab in a patient with dupilumab-related conjunctivitis

DSpace/Manakin Repository

Recurrence of conjunctival goblet cells after discontinuation of dupilumab in a patient with dupilumab-related conjunctivitis

Voorberg, A N; den Dunnen, W F A; Wijdh, R H J; de Bruin-Weller, M S; Schuttelaar, M L A

(2020) JEADV : journal of the European Academy of Dermatology and Venereology, volume 34, issue 2, pp. e64 - e66

(Letter)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Adult, Antibodies, Monoclonal, Humanized/adverse effects, Conjunctiva/drug effects, Conjunctivitis/chemically induced, Dermatitis, Atopic/drug therapy, Female, Goblet Cells/pathology, Humans, Interleukin-4 Receptor alpha Subunit/drug effects, Case Reports, Letter

DOI: https://doi.org/10.1111/jdv.15914

ISSN: 0926-9959

Publisher: Wiley-Blackwell

(Peer reviewed)